Skip to main content
Article
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Neuro-Oncology
  • Michael McDermott, Miami Neuroscience Institute
Publication Date
11-2-2021
Content Type
application/pdf
PubMed ID:
33823014
Additional Authors:

Additional authors and institutional affiliations

Citation Information

Neuro-Oncology (2021) 23(11):1872-1884